Immuneering (IMRX) Operating Income (2020 - 2026)
Immuneering (IMRX) recorded Operating Income of -$19 million in Q2 2026, compared with -$14.76 million a year earlier.
Powered by 
Analysis
Immuneering (IMRX) Operating Income (2020 - 2026) Analysis & Trends
On a TTM basis, Immuneering's Operating Income came in at -$63.47 million as of Jun 30, 2026; for FY2025, it came in at -$59.38 million.
- Across earlier years, Operating Income came in at -$64.07 million in FY2024, -$58.41 million in FY2023, -$51.74 million in FY2022 and -$33.89 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Operating Income in data going back to Q2 2020.
- Per Business Quant, the preceding three quarters came in at -$15.34 million (Q1 2026), -$13.75 million (Q4 2025) and -$15.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Immuneering | 269.14 Mn | 269.14 Mn | - | -19.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.00 Mn |
| Mar 31, 2026 | -15.34 Mn |
| Dec 31, 2025 | -13.75 Mn |
| Sep 30, 2025 | -15.38 Mn |
| Jun 30, 2025 | -14.76 Mn |
| Mar 31, 2025 | -15.48 Mn |
| Dec 31, 2024 | -18.56 Mn |
| Sep 30, 2024 | -15.27 Mn |
| Jun 30, 2024 | -14.91 Mn |
| Mar 31, 2024 | -15.33 Mn |
| Dec 31, 2023 | -16.30 Mn |
| Sep 30, 2023 | -13.93 Mn |
| Jun 30, 2023 | -13.50 Mn |
| Mar 31, 2023 | -14.68 Mn |
| Dec 31, 2022 | -13.99 Mn |
| Sep 30, 2022 | -13.19 Mn |
| Jun 30, 2022 | -11.65 Mn |
| Mar 31, 2022 | -12.93 Mn |
| Dec 31, 2021 | -11.12 Mn |
| Sep 30, 2021 | -8.54 Mn |
API Access
Immuneering Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();